The Canadian Hematology Consensus Group, or CHCG, is a national collaboration of Canadian hematologists and healthcare professionals dedicated to improving patient care through the development of National consensus recommendations in hematologic malignancies.
Our most recent consensus paper has been published in Current Oncology. The paper provides treatment recommendations for hematologists managing patients with relapsed and/or refractory FL. In this episode, we will discuss the content of the paper with Dr Lemieux, who is a lead author and a member of the CHCG scientific committee.
Our Guest
Dr Lemieux is a Hematologist at the CHU de Québec-Université Laval in Quebec city, Quebec and a Canadian expert in the treatment of follicular lymphoma.
This podcast episode has been funded by Merck Canada.
Podden och tillhörande omslagsbild på den här sidan tillhör
IMPACT Medicom. Innehållet i podden är skapat av IMPACT Medicom och inte av,
eller tillsammans med, Poddtoppen.
